Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Catani

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|September 1, 1993
Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignanciesL Catani, L Gugliotta, M Mattioli Belmonte, et al.
Haematologica|June 1, 1991
[Essential thrombocythemia: therapy with alpha interferons]L Gugliotta, L Catani, N Vianelli, et al.
Haematologica|July 1, 1992
In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemiaL Catani, L Gugliotta, G Zauli, et al.
Blood|February 15, 1997
Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factorR M Lemoli, A Tafuri, A Fortuna, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2007
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injuryP Caraceni, F Giannone, L Catani, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2008
Stem cell mobilization and collection in patients with liver cirrhosisS Lorenzini, A Isidori, L Catani, et al.
European Journal of Haematology|September 21, 2000
All-trans retinoic acid significantly reduces the incidence of early hemorrhagic death during induction therapy of acute promyelocytic leukemiaG Visani, L Gugliotta, P Tosi, et al.
Leukemia|August 30, 2002
Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesisL Catani, N Vianelli, M Amabile, et al.
Leukemia|March 25, 2015
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosisF Palandri, R Latagliata, N Polverelli, et al.
The Review of Scientific Instruments|March 8, 2013
Characterization of the THz radiation source at the Frascati linear acceleratorE Chiadroni, M Bellaveglia, P Calvani, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|September 1, 1993
Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignanciesL Catani, L Gugliotta, M Mattioli Belmonte, et al.
Haematologica|June 1, 1991
[Essential thrombocythemia: therapy with alpha interferons]L Gugliotta, L Catani, N Vianelli, et al.
Haematologica|July 1, 1992
In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemiaL Catani, L Gugliotta, G Zauli, et al.
Blood|February 15, 1997
Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factorR M Lemoli, A Tafuri, A Fortuna, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2007
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injuryP Caraceni, F Giannone, L Catani, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2008
Stem cell mobilization and collection in patients with liver cirrhosisS Lorenzini, A Isidori, L Catani, et al.
European Journal of Haematology|September 21, 2000
All-trans retinoic acid significantly reduces the incidence of early hemorrhagic death during induction therapy of acute promyelocytic leukemiaG Visani, L Gugliotta, P Tosi, et al.
Leukemia|August 30, 2002
Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesisL Catani, N Vianelli, M Amabile, et al.
Leukemia|March 25, 2015
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosisF Palandri, R Latagliata, N Polverelli, et al.
The Review of Scientific Instruments|March 8, 2013
Characterization of the THz radiation source at the Frascati linear acceleratorE Chiadroni, M Bellaveglia, P Calvani, et al.
Pageof 8